FindTrial
Sign In

A study to observe abnormal blood sugar levels in patients undergoing major abdominal surgeries and it s side effects after surgery in patients having a normal blood sugar

Study of Perioperative Dysglycemia in Upper Abdominal Gastrointestinal and Hepato-Pancreato-Biliary Surgeries and Its Postoperative Adverse Events in Non-Diabetic SuRgical Patients (SUGAR Trial) - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/083143
Enrollment
208
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C15-C26- Malignant neoplasms of digestive organs

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Sohan Lal Solanki
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non-diabetic upper abdominal gastro-intestinal surgeries and the hepato-pancreato-biliary surgeries between age 18-90 years. ASA 1-3

Exclusion criteria

Exclusion criteria: Patients posted for staging Laparoscopy or diagnostic laparoscopy only Patients with endocrinal disorders like Cushing syndrome,Hyperaldosteronism Bilateral adrenal Hyperplasia Patients on steroids(intravenous and inhaled)

Design outcomes

Primary

MeasureTime frame
To observe the incidence and patterns of perioperative dysglycemia (hyperglycemia and hypoglycemia) in patients undergoing upper abdominal gastrointestinal and hepato-pancreato-biliary surgeries.Timepoint: At the time of admission for current surgery, Before induction of anaesthesia, 2 hours after induction of anaesthesia, 4 hours after induction of anaesthesia, End of surgery in OT, 24 hours after surgery and 48 hours after surgery—

Secondary

MeasureTime frame
1)To determine the proportion of patients requiring intro operative and postoperative insulin infusions up to 48 hours 2)Number of patients on insulin beyond 48 hours postoperatively 3) To evaluate postoperative complications such as : Infectious complications (eg pneumonia,surgical site infections) Prolonged hospital stay Re-exploration Anastomotic leak Acute kidney injury MortalityTimepoint: From intraoperative period to upto 30 days after surgery.—

Countries

India

Contacts

Public ContactDr Sohan Lal Solanki

Tata Memorial Hospital Mumbai

sohan.solanki@gmail.com9869253201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026